Nutralife Biosciences Stock Gross Profit
Nutralife Biosciences fundamentals help investors to digest information that contributes to Nutralife Biosciences' financial success or failures. It also enables traders to predict the movement of Nutralife Pink Sheet. The fundamental analysis module provides a way to measure Nutralife Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nutralife Biosciences pink sheet.
Nutralife |
Nutralife Biosciences Company Gross Profit Analysis
Nutralife Biosciences' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Nutralife Biosciences Gross Profit | 83.59 K |
Most of Nutralife Biosciences' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nutralife Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Nutralife Biosciences reported 83.59 K of gross profit. This is 100.0% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The gross profit for all United States stocks is 100.0% higher than that of the company.
Nutralife Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nutralife Biosciences' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nutralife Biosciences could also be used in its relative valuation, which is a method of valuing Nutralife Biosciences by comparing valuation metrics of similar companies.Nutralife Biosciences is currently under evaluation in gross profit category among its peers.
Nutralife Fundamentals
Return On Equity | -14.26 | |||
Return On Asset | -0.28 | |||
Operating Margin | (3.80) % | |||
Current Valuation | 11.61 M | |||
Shares Outstanding | 176.62 M | |||
Shares Owned By Insiders | 45.95 % | |||
Price To Book | 85.51 X | |||
Price To Sales | 14.09 X | |||
Revenue | 626.62 K | |||
Gross Profit | 83.59 K | |||
EBITDA | (5.71 M) | |||
Net Income | (5.83 M) | |||
Cash And Equivalents | 51.8 K | |||
Total Debt | 10 K | |||
Current Ratio | 0.10 X | |||
Book Value Per Share | (0.01) X | |||
Cash Flow From Operations | (487.39 K) | |||
Earnings Per Share | (0.03) X | |||
Number Of Employees | 12 | |||
Beta | -0.9 | |||
Market Capitalization | 6.62 M | |||
Total Asset | 4.85 M | |||
Net Asset | 4.85 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Nutralife Pink Sheet
If you are still planning to invest in Nutralife Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nutralife Biosciences' history and understand the potential risks before investing.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |